1. Home
  2. TRAK vs CRBU Comparison

TRAK vs CRBU Comparison

Compare TRAK & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$10.38

Market Cap

212.5M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.53

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRAK
CRBU
Founded
1990
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.5M
203.9M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
TRAK
CRBU
Price
$10.38
$1.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.00
AVG Volume (30 Days)
81.0K
1.2M
Earning Date
02-17-2026
03-09-2026
Dividend Yield
0.78%
N/A
EPS Growth
19.98
N/A
EPS
0.36
N/A
Revenue
$23,136,391.00
$9,295,000.00
Revenue This Year
$8.29
$0.22
Revenue Next Year
$24.17
$4.48
P/E Ratio
$28.67
N/A
Revenue Growth
11.05
N/A
52 Week Low
$10.03
$0.66
52 Week High
$23.72
$3.54

Technical Indicators

Market Signals
Indicator
TRAK
CRBU
Relative Strength Index (RSI) 35.10 46.47
Support Level $10.03 $1.48
Resistance Level $10.75 $1.65
Average True Range (ATR) 0.44 0.11
MACD 0.04 0.01
Stochastic Oscillator 15.86 38.89

Price Performance

Historical Comparison
TRAK
CRBU

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: